Investigator Studies Program (MISP): Fertility
Effective November 2019, the Fertility Investigator Studies Program (MISP) Committee will accept proposals within our current areas of interest (AOI). This is a competitive process that will be conducted by the Fertility MISP in 2020. Decisions will be made on the basis of scientific merit and strategic fit within the AOI.
The following areas are of interest to Investigator Studies Program Committee:
- Studies investigating modifications of corifollitropin alfa (CFA) stimulation protocols to the freeze-all setting aimed at optimizing ART cycle outcomes, time to pregnancy, flexibility and cost-efficiency.
- Studies investigating optimizing CFA use in patients with a predicted poor oocyte yield response.
- Studies that use innovative technology and algorithms to enhance embryo selection with CFA vs. conventional gonadotropins.
- Studies that evaluate further optimization of the post-CFA follicular stimulating hormone (rFSH) regimen and determine the parameters to support optimization (e.g. # follicles, age, endocrine environment)
- Studies evaluating Progestin Primed Ovarian Stimulation (PPOS) in CFA versus recombinant (r)FSH cycles for ovarian response and donor compliance
- Evaluate the effect of modifications of ovarian stimulation on late follicular progesterone rise (eg. CFA, recombinant Luteinizing Hormone, human Menopausal Gonadotropin
Please complete a full protocol and detailed budget via Visiontracker
, the Company's on-line study management system (in US) or your MSD country representative (outside US). The proposals will be collectively reviewed and selected by the Fertility MISP Committee.
This site is intended for US investigators only. Investigators outside of the US interested in submitting research proposals to the Investigator
Studies Program should contact their local MSD office